 |
市場調査レポート
商品コード
1373882
局所ドラッグデリバリーの世界市場の規模、シェア、成長分析：タイプ別、用途別 - 産業予測（2023年～2030年）Global Topical Drug Delivery Market Size, Share, Growth Analysis, By Type(Topical Drug Delivery, Inhalation Drug Delivery), By Application(Cardiovascular Diseases, Respiratory Diseases) - Industry Forecast 2023-2030 |
||||||
| 局所ドラッグデリバリーの世界市場の規模、シェア、成長分析：タイプ別、用途別 - 産業予測（2023年～2030年） |
|
出版日: 2023年10月13日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の局所ドラッグデリバリーの市場規模は、2021年に960億米ドルとなり、2022年の1,024億3,000万米ドルから2030年までに1,720億9,000万米ドルに達し、予測期間（2023年～2030年）にCAGRで6.7%の成長が見込まれています。
市場は近年大きな成長を示しており、今後も安定したペースで拡大が続くと予測されます。にきび、乾癬、湿疹、皮膚炎などの症状には、患部への効果的で的を絞ったドラッグデリバリーが必要です。これらの皮膚疾患の罹患率の上昇と、治療オプションの改善に対する需要の高まりが、局所ドラッグデリバリーシステムの採用に拍車をかけています。さらに、世界の高齢化も市場拡大に寄与しています。高齢化に伴い、関節炎、神経障害性疼痛、糖尿病性潰瘍などの慢性疾患の有病率が増加します。局所ドラッグデリバリーは、これらの疾患の管理、創傷治癒の促進、疼痛緩和に向けた、非侵襲性の便利なアプローチを提供します。高齢者の医療ニーズの高まりが、先進の局所ドラッグデリバリーシステムに対する需要を押し上げています。局所ドラッグデリバリーは、レチノイドやヒアルロン酸などの有効成分を送達し、皮膚の外見を向上させ、老化の兆候と闘う上で重要な役割を果たしています。美容皮膚科学の人気の高まりが、革新的な局所ドラッグデリバリー技術の開発と採用に拍車をかけています。
世界の局所ドラッグデリバリー市場の地域考察
世界市場においてもっとも支配的な地域は北米です。北米は医療インフラが整備されており、先進の研究施設があり、慢性疾患の有病率が高いため、局所ドラッグデリバリーシステムの需要が高まっています。同地域は製薬企業の強いプレゼンスと、革新的なドラッグデリバリー技術に焦点を当てた広範な研究開発活動が行われていることが特徴です。さらに、政府の積極的な取り組み、強固な償還政策、先進医療技術の高い採用率が、世界市場における北米の優位性に寄与しています。
世界の局所ドラッグデリバリーの市場力学
世界の局所ドラッグデリバリー市場の促進要因
利便性と非侵襲性
局所ドラッグデリバリーは、便利で非侵襲性の投薬方法を提供し、注射や経口薬の必要性を排除します。この特徴は、注射針を怖がる患者や、より快適で手間のかからないアプローチを好む患者にとって特に有益です。局所製剤の使用は、治療のアドヒアランスと全体的な患者体験を向上させるため、特に小児や注射針恐怖症の患者にとって好ましい選択肢となります。
世界の局所ドラッグデリバリー市場における抑制要因
製剤化の課題
安定した効果的な外用製剤の開発には大きな課題があります。薬物の溶解性、安定性、賦形剤との適合性、求められる放出プロファイルの達成などのさまざまな要因が、製剤開発の複雑さの要因となっています。製剤は最適な治療効果を確保しつつ厳しい品質基準と規制要件を満たさなければならないため、こうした製剤上の課題が局所用医薬品の入手可能性と商業的実現性に影響を及ぼす可能性があります。
世界のドラッグデリバリー市場の動向
老年人口の皮膚疾患：皮膚疾患の有病率の増加、老年人口の増加、非侵襲性のドラッグデリバリー手法に対する需要の高まりが市場を牽引しています。また、マイクロニードルやナノキャリアーなどの新しい局所ドラッグデリバリー技術の開発も、市場の成長を後押しすると予測されます。しかし、局所ドラッグデリバリー製品の高い価格と厳しい規制要件が、市場成長を抑制する可能性があります。
当レポートでは、世界の局所ドラッグデリバリー市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界の局所ドラッグデリバリー市場：タイプ別
- 市場の概要
- 局所ドラッグデリバリー
- 吸入ドラッグデリバリー
- 注射ドラッグデリバリー、経口ドラッグデリバリー
世界の局所ドラッグデリバリー市場：用途別
- 市場の概要
- 心血管疾患
- 呼吸器疾患
- 糖尿病
- 腫瘍、中枢神経系（CNS）障害
世界の局所ドラッグデリバリーの市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Johnson & Johnson (US)
- Novartis AG (Switzerland)
- GlaxoSmithKline plc (United Kingdom)
- Pfizer Inc. (US)
- Bayer AG (Germany)
- Sanofi S.A. (France)
- Merck & Co., Inc. (US)
- Eli Lilly and Company (US)
- AstraZeneca PLC (United Kingdom)
- Gilead Sciences, Inc. (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sun Pharmaceutical Industries Ltd. (India)
- LEO Pharma A/S (Denmark)
- Perrigo Company plc (Ireland)
- Mylan N.V. (US)
- Galderma S.A. (Switzerland)
- Glenmark Pharmaceuticals Ltd. (India)
- Almirall, S.A. (Spain)
- Dermira, Inc. (US)
- Fougera Pharmaceuticals Inc. (US)
Global Topical Drug Delivery Market size was valued at USD 96 billion in 2021 and is poised to grow from USD 102.43 billion in 2022 to USD 172.09 billion by 2030, growing at a CAGR of 6.7% in the forecast period (2023-2030).
The global topical drug delivery market has experienced significant growth in recent years and is expected to continue expanding at a steady pace. Conditions like acne, psoriasis, eczema, and dermatitis require effective and targeted drug delivery to the affected areas. The rising incidence of these skin ailments, coupled with the growing demand for improved treatment options, has fueled the adoption of topical drug delivery systems. Moreover, the ageing population worldwide has contributed to the market expansion. As individuals age, the prevalence of chronic conditions such as arthritis, neuropathic pain, and diabetic ulcers increases. Topical drug delivery offers a non-invasive and convenient approach for managing these conditions, promoting wound healing, and providing pain relief. The elderly population's rising healthcare needs have driven the demand for advanced topical drug delivery systems. Topical drug delivery plays a crucial role in delivering active ingredients, such as retinoids and hyaluronic acid, to enhance skin appearance and combat ageing signs. The growing popularity of cosmetic dermatology has fueled the development and adoption of innovative topical drug delivery technologies.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Topical Drug Delivery Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Topical Drug Delivery Market Segmental Analysis
The global topical drug delivery market is segmented by type, application, and region. Based on type, the market can be segmented into Topical Drug Delivery, Inhalation Drug Delivery, Injectable Drug Delivery, and Oral Drug Delivery. Based on application, the market is segmented Cardiovascular Diseases, Respiratory Diseases, Diabetes, Oncology, and Central Nervous System (CNS) Disorders. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Topical Drug Delivery Market Regional Insights
In the global topical drug delivery market, the most dominant region is North America. North America has a well-established healthcare infrastructure, advanced research facilities, and a high prevalence of chronic diseases, driving the demand for topical drug delivery systems. The region is characterised by a strong presence of pharmaceutical companies and extensive R&D activities focused on innovative drug delivery technologies. Additionally, favourable government initiatives, robust reimbursement policies, and a high adoption rate of advanced healthcare technologies contribute to the dominance of North America in the global topical drug delivery market.
Global Topical Drug Delivery Market Dynamics
Drivers of the Global Topical Drug Delivery Market
Convenience and Non-Invasiveness
Topical drug delivery offers a convenient and non-invasive method of administering medications, eliminating the requirement for injections or oral medications. This feature is particularly advantageous for patients who may have a fear of needles or prefer a more comfortable and hassle-free approach. The use of topical formulations enhances treatment adherence and overall patient experience, making it a preferred option, especially for children and individuals with needle phobia.
Restraints In the Global Topical Drug Delivery Market
Formulation Challenges
The development of stable and effective topical formulations can present significant challenges. Various factors, including drug solubility, stability, compatibility with excipients, and achieving the desired release profile, contribute to the complexity of formulation development. These formulation challenges can impact the availability and commercial viability of topical drug products, as the formulation must meet stringent quality standards and regulatory requirements while ensuring optimal therapeutic efficacy.
Market Trends of the Global Topical Drug Delivery Key
Skin Issues among the Aging Population: The market is driven by the increasing prevalence of skin diseases, the rising ageing population, and the growing demand for non-invasive drug delivery methods. The development of new topical drug delivery technologies, such as microneedles and nanocarriers, is also expected to boost the market growth. However, the high cost of topical drug delivery products and the stringent regulatory requirements could restrain the market growth.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Topical Drug Delivery Market by Type
- Market Overview
- Topical Drug Delivery
- Inhalation Drug Delivery
- Injectable Drug Delivery and Oral Drug Delivery.
- Global Topical Drug Delivery Market by Application
- Market Overview
- Cardiovascular Diseases
- Respiratory Diseases
- Diabetes
- Oncology and Central Nervous System (CNS) Disorders.
- Global Topical Drug Delivery Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LEO Pharma A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Galderma S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Glenmark Pharmaceuticals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Almirall, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dermira, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fougera Pharmaceuticals Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
